Featured Research

from universities, journals, and other organizations

Protective Gene May Enhance Vaccine Responses

Date:
August 16, 2004
Source:
University Of Chicago Medical Center
Summary:
Researchers from the University of Chicago have discovered the first of a new class of "protective factors" that appear to be required for the development of memory T cells, the cells that form the core of a vaccine response.

Researchers from the University of Chicago have discovered the first of a new class of "protective factors" that appear to be required for the development of memory T cells, the cells that form the core of a vaccine response. The finding could help scientists create more effective vaccines and may lead to potent immune system-based therapies against diseases that have previously eluded vaccines, such as cancer or AIDS.

When the immune system detects an invader, such as a virus, T cells with an affinity for that particular invader multiply rapidly, attack and eliminate infected cells. Once the infection is cleared, however, 90 to 95 percent of those T cells die off, a process called contraction. The five percent or so that survive are known as memory T cells. If a similar infection recurs, these experienced warriors are prepared to rush to the site, recognize that invader and eradicate it again.

Scientists know a great deal about the rapid proliferation and differentiation of these T cells but very little about the factors that regulate contraction. In the September, 2004, issue of Nature Immunology – published on-line August 15 -- the researchers show that activation of the gene for the Serine protease inhibitor 2A (Spi2A) can prevent the death of T cells during the contraction phase, resulting in about five times as many memory T cells.

"Drugs based on protective factors such as Spi2A could provide an enormous boost to vaccines," said study author Philip Ashton-Rickardt, professor of pathology and a member of the committee on immunology at the University of Chicago. "This could allow us to extend the duration of an immune response against chronic infections or to focus the power of the immune system on tumor cells, targets that have thus far been quite elusive."

The researchers began by screening approximately 11,000 genes from mouse T cells, to find the small number of genes that were more active in the T cells that survived the contraction phase after exposure to a virus. Then they focused on the likely candidates, genes that interfered with the processes that trigger cell death. Their search led them to Spi2A.

Spi2A, they found, was produced in higher amounts in memory T cells. It suppressed cathepsin B, a potent digestive enzyme that can induce cell death. T cell populations in which Spi2A levels were reduced produced fewer memory cells. As a consequence, mice with low Spi2A levels produced a severely diminished response to the virus when exposed to it a second time.

On the other hand, mice with elevated Spi2A produced up to five times the normal number of memory T cells. When faced with the virus a second time, these memory T cells produced an overwhelming response, completely eradicating the infection within hours.

"Spi2A appears to play a crucial role in regulating contraction," Ashton-Rickardt said. "Increasing Spi2A levels alone can increase the survival of memory T cells from the standard 5 to 10 percent up to about 40 percent.

His lab has already begun to test small molecules that mimic the effects of Spi2A and could be given along with a vaccine.

This finding may also provide clues about how to reverse the process, suggesting ways to reduce or eliminate memory T cells responsible the unwanted immune responses that cause autoimmune diseases such as arthritis.

Additional authors of the paper include Ni Lui, Tiphanie Phillips, Minling Zhang, Yue Wang, Joseph Opferman and Ramila Shah, all from the University of Chicago. The National Institutes of Health funded the study.


Story Source:

The above story is based on materials provided by University Of Chicago Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Chicago Medical Center. "Protective Gene May Enhance Vaccine Responses." ScienceDaily. ScienceDaily, 16 August 2004. <www.sciencedaily.com/releases/2004/08/040816085047.htm>.
University Of Chicago Medical Center. (2004, August 16). Protective Gene May Enhance Vaccine Responses. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2004/08/040816085047.htm
University Of Chicago Medical Center. "Protective Gene May Enhance Vaccine Responses." ScienceDaily. www.sciencedaily.com/releases/2004/08/040816085047.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins